SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Y Zhang, J Dai, H Deng, H Wan, M Liu, J Wang, S Li, X Li, H Tang, miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop, British Journal of Cancer, 2015, 112, 2, 365

    CrossRef

  2. 2
    Shi-yan Yan, Mei-mei Chen, Guang-ming Li, Yu-qin Wang, Jian-gao Fan, MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN, Tumor Biology, 2015,

    CrossRef

  3. 3
    Daniel L. Van den Hove, Konstantinos Kompotis, Roy Lardenoije, Gunter Kenis, Jonathan Mill, Harry W. Steinbusch, Klaus-Peter Lesch, Carlos P. Fitzsimons, Bart De Strooper, Bart P.F. Rutten, Epigenetically regulated microRNAs in Alzheimer's disease, Neurobiology of Aging, 2014, 35, 4, 731

    CrossRef

  4. 4
    Sacha I Rothschild, microRNA therapies in cancer, Molecular and Cellular Therapies, 2014, 2, 1, 7

    CrossRef

  5. 5
    Ewelina Maria Kałużna, MicroRNA-155 and microRNA-196b: promising biomarkers in hepatitis C virus infection?, Reviews in Medical Virology, 2014, 24, 3
  6. 6
    Manuele Gori, Mario Arciello, Clara Balsano, MicroRNAs in Nonalcoholic Fatty Liver Disease: Novel Biomarkers and Prognostic Tools during the Transition from Steatosis to Hepatocarcinoma, BioMed Research International, 2014, 2014, 1

    CrossRef

  7. 7
    Tong Li, Jue Yang, Xiaobo Lv, Kunmei Liu, Chao Gao, Yingying Xing, Tao Xi, miR-155 regulates the proliferation and cell cycle of colorectal carcinoma cells by targeting E2F2, Biotechnology Letters, 2014, 36, 9, 1743

    CrossRef

  8. 8
    Xiaojun Li, Jiangbo Zhang, Ziwei Yang, Jingting Kang, Suzhen Jiang, Ting Zhang, Tingting Chen, Meng Li, Quanjun Lv, Xiangmei Chen, Malcolm A. McCrae, Hui Zhuang, Fengmin Lu, The function of targeted host genes determines the oncogenicity of HBV integration in hepatocellular carcinoma, Journal of Hepatology, 2014, 60, 5, 975

    CrossRef

  9. 9
    Jun Qin, Meng Luo, Haixin Qian, Wei Chen, Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1, Gene, 2014, 538, 2, 342

    CrossRef

  10. 10
    Xiaodong Guo, Mei Yang, Hao Gu, Jingmin Zhao, Lin Zou, Decreased expression of SOX6 confers a poor prognosis in hepatocellular carcinoma, Cancer Epidemiology, 2013, 37, 5, 732

    CrossRef

  11. 11
    Xin-Long Yan, Ya-Li Jia, Lin Chen, Quan Zeng, Jun-Nian Zhou, Chun-Jiang Fu, Hai-Xu Chen, Hong-Feng Yuan, Zhi-Wei Li, Lei Shi, Ying-Chen Xu, Jing-Xue Wang, Xiao-Mei Zhang, Li-Juan He, Chao Zhai, Wen Yue, Xue-Tao Pei, Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: Role of the S100A4-miR155-SOCS1-MMP9 axis, Hepatology, 2013, 57, 6
  12. 12
    Xiangmei Chen, Ling Zhang, Ting Zhang, Meili Hao, Xiaolei Zhang, Jiangbo Zhang, Qing Xie, Yongfeng Wang, Mingzhou Guo, Hui Zhuang, Fengmin Lu, Methylation-mediated repression of microRNA 129-2 enhances oncogenic SOX4 expression in HCC, Liver International, 2013, 33, 3
  13. 13
    Isamu Hoshino, Hisahiro Matsubara, MicroRNAs in cancer diagnosis and therapy: from bench to bedside, Surgery Today, 2013, 43, 5, 467

    CrossRef

  14. 14
    Patricia A. Thibault, Joyce A. Wilson, Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host, Pharmacological Research, 2013, 75, 48

    CrossRef

  15. 15
    Y. Dai, Z. Qiu, Z. Diao, L. Shen, P. Xue, H. Sun, Y. Hu, MicroRNA-155 inhibits proliferation and migration of human extravillous trophoblast derived HTR-8/SVneo cells via down-regulating cyclin D1, Placenta, 2012, 33, 10, 824

    CrossRef

  16. 16
    Xiaojun Wang, Ji Chen, Feng Li, Yanting Lin, Xiaoping Zhang, Zhongwei Lv, Jiaji Jiang, MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin, Biochemical and Biophysical Research Communications, 2012, 428, 4, 525

    CrossRef

  17. 17
    H.M. El Tayebi, K.A. Hosny, G. Esmat, K. Breuhahn, Ahmed Ihab Abdelaziz, miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma, FEBS Letters, 2012, 586, 19, 3309

    CrossRef